UTERUS PRESERVING TREATMENT MODALITIES FOR ABNORMAL INVASIVE PLACENTA: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/md0b1z50Keywords:
Abnormal invasive placenta, conservative management, surgery, uterus preserving treatmentAbstract
Background: When a focal accreta is identified, conservative intervention may be considered, such as preserving the uterus and placenta and then enduring methotrexate therapy or pelvic artery embolisation. In spite of this, surgical treatment remains the gold standard for the condition.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2013 and 2023 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 401 articles, whereas the results of our search on SagePub brought up 289 articles. The results of the search conducted for the last year of 2013 yielded a total 43 articles for PubMed and 31 articles for SagePub. In the end, we compiled a total of 20 papers, 12 of which came from PubMed and 8 of which came from SagePub. We included seven research that met the criteria.
Conclusion: Due to the intricacy of surgery, conservative management should be reserved for individuals who are interested in preserving their fertility as well as those who have major disease.
References
Guleria K, Gupta B, Agarwal S, Suneja A, Vaid N, Jain S. Abnormally invasive placenta: changing trends in diagnosis and management. Acta Obstet Gynecol Scand. 2013;92(4):461–4.
Iacovelli A, Liberati M, Khalil A, Timor-Trisch I, Leombroni M, Buca D, et al. Risk factors for abnormally invasive placenta: a systematic review and meta-analysis. J Matern neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2020 Feb;33(3):471–81.
Jauniaux ERM, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a. Bjog. 2018;126(1):e1–48.
Leanza V, Verzì MG, Genovese F, Colaleo FM, Leanza G, Palumbo M. Central placenta praevia accreta with focal bladder percretism. Conservative management. Ann Ital Chir. 2021 May;10.
Jauniaux E, Bunce C, Grønbeck L, Langhoff-Roos J. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol. 2019;221(3):208–18.
Kaelin Agten A, Jones NW. Abnormally invasive placentation: diagnosis and management. Obstet Gynaecol Reprod Med [Internet] 2019;29(7):189–94. Available from: https://www.sciencedirect.com/science/article/pii/S1751721419300740
Varlas VN, Bors RG, Birsanu S, Maxim B, Clotea E, Mihailov M. Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary center. J Med Life. 2021;14(3):367–75.
Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet Off organ Int Fed Gynaecol Obstet. 2018 Mar;140(3):274–80.
Collins SL, Ashcroft A, Braun T, Calda P, Langhoff‐Roos J, Morel O, et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Vol. 47, Ultrasound in Obstetrics & Gynecology. John Wiley & Sons, Ltd Chichester, UK; 2016. p. 271–5.
Bauer ST, Bonanno C. Abnormal placentation. Semin Perinatol. 2009 Apr;33(2):88–96.
Baughman WC, Corteville JE, Shah RR. Placenta Accreta: Spectrum of US and MR Imaging Findings. RadioGraphics [Internet] 2008 Nov 1;28(7):1905–16. Available from: https://doi.org/10.1148/rg.287085060
Collins SL, Alemdar B, van Beekhuizen HJ, Bertholdt C, Braun T, Calda P, et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol. 2019 Jun;220(6):511–26.
Martimucci K, Bilinski R, Perez AM, Kuhn T, Al-Khan A, Alvarez-Perez JR. Interpregnancy interval and abnormally invasive placentation. Acta Obstet Gynecol Scand. 2019 Feb;98(2):183–7.
Gu Y, Zhou Y, Li L, Li H, Wang S, Wang Y, et al. Cook Cervical Ripening Balloon for placenta accreta spectrum disorders with placenta previa: a novel approach to uterus preserving. Arch Gynecol Obstet. 2022 Dec;306(6):1979– 87.
Gulucu S, Uzun KE, Ozsoy AZ, Delibasi IB. Retrospective evaluation of peripartum hysterectomy patients: 8 years’ experience of tertiary health care. Niger J Clin Pract. 2022 Apr;25(4):483–9.
Babaei MR, Oveysi Kian M, Naderi Z, Khodaverdi S, Raoofi Z, Javanmanesh F, et al. Methotrexate infusion followed by uterine artery embolisation for the management of placental adhesive disorders: a case series. Clin Radiol. 2019 May;74(5):378–83.
Kilicci C, Ozkaya E, Eser A, Bostanci EE, Sanverdi I, Abide Yayla C, et al. Planned cesarean hysterectomy versus modified form of segmental resection in patients with placenta percreta. J Matern neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2018 Nov;31(22):2935–40.
Chung MY, Cheng YKY, Yu SCH, Sahota DS, Leung TY. Nonremoval of an abnormally invasive placenta at cesarean section with postoperative uterine artery embolization. Acta Obstet Gynecol Scand. 2013;92(11):1250–5.
Hwang SM, Jeon GS, Kim MD, Kim SH, Lee JT, Choi MJ. Transcatheter arterial embolisation for the management of obstetric haemorrhage associated with placental abnormality in 40 cases. Eur Radiol. 2013;23:766–73.
Warshak CR, Eskander R, Hull AD, Scioscia AL, Mattrey RF, Benirschke K, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol. 2006;108(3 Part 1):573–81.
Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG An Int J Obstet Gynaecol. 2009;116(5):648–54.
Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2005;26(1):89–96.
Steins Bisschop CN, Schaap TP, Vogelvang TE, Scholten PC. Invasive placentation and uterus preserving treatment modalities: a systematic review. Arch Gynecol Obstet. 2011;284:491–502.
Panici PB, Anceschi M, Borgia ML, Bresadola L, Masselli G, Parasassi T, et al. Intraoperative aorta balloon occlusion: fertility preservation in patients with placenta previa accreta/increta. J Matern Neonatal Med. 2012;25(12):2512–6.
Timmermans S, van Hof AC, Duvekot JJ. Conservative management of abnormally invasive placentation. Obstet
Gynecol Surv. 2007;62(8):529–39.
Kayem G, Davy C, Goffinet F, Thomas C, Clément D, Cabrol D. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol. 2004;104(3):531–6.
Bretelle F, Courbière B, Mazouni C, Agostini A, Cravello L, Boubli L, et al. Management of placenta accreta: morbidity and outcome. Eur J Obstet Gynecol Reprod Biol. 2007;133(1):34–9.
Dinkel H-P, Dürig P, Schnatterbeck P, Triller J. Percutaneous treatment of placenta percreta using coil embolization. J Endovasc Ther. 2003;10(1):158–62.
Committee opinion no. 529: placenta accreta. Obstet Gynecol. 2012 Jul;120(1):207–11.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
